Video
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/HV2DWE7FSJGK5LJPJBVEJYAXRY.png)
Duración: 02:28
COVID-19: ¿Qué vacunas son eficaces contra la nueva variante Ómicron?
Poco a poco se van conociendo más datos sobre la variante Ómicron, la nueva cepa que amenaza al mundo tras hacerse dominante en Sudáfrica en pocas semanas. La alta transmisibilidad que está caracterizando a Ómicron desde que apareciera el pasado 24 de noviembre ha provocado que diversas personas se pregunten si las actuales vacunas son efectivas contra esta nueva variante.
- 9 de diciembre de 2021 11:16 a.m.
- Duración: 02:28
PLAYLIST
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/HV2DWE7FSJGK5LJPJBVEJYAXRY.png)
COVID-19: ¿Qué vacunas son eficaces contra la nueva variante Ómicron?
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/PFH4CS565NEXVGZFDRPCMNL6OI.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/OLNVIHO36RGNBC5OKLVLMA56SI.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/2276GOELEJFZRCTCOXLJIXQ7L4.png)
:quality(75)/cdn.jwplayer.com/v2/media/k5ANEfax/poster.jpg)
Lo último en Mundo
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/XGHYCLPQ2FDDFHYNGX4RJ7GVIY.png)
:quality(75)/cdn.jwplayer.com/v2/media/mfbgq6S1/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/hAt46tIH/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/RzRN3okv/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/EOZQTBZERVADRHLMY2D25TY6DY.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/CWiNeRJW/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/Q6VI4GFQJNDXHJNIDFZBCXYJCU.png)
:quality(75)/cdn.jwplayer.com/v2/media/1Wzbz1Jr/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/AEPGO3SP3ZDN7IN5NNVK6PGGB4.png)
:quality(75)/cdn.jwplayer.com/v2/media/EuObDf26/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/6H46LYZN6ZBJZIJ4K4ZQOWZGTA.png)
:quality(75)/cdn.jwplayer.com/v2/media/4NnkM9Bz/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/aAoZyyJt/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/PQmoXxDb/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ZpvMBxDi/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/0f9a2fKn/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/O23LPBHQIZFG3DSLHKLZIRX2D4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/T3IGNCGW6ZFPJJSBCD7SCP6RWQ.png)
:quality(75)/cdn.jwplayer.com/v2/media/QCjndr6r/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/Ga0PtIGC/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/GPKZB3R6MFGSZPTKIVB3TELIJI.png)
:quality(75)/cdn.jwplayer.com/v2/media/Eay6KXyw/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/B6wbn2mx/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/blYS7Abv/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/PFH4CS565NEXVGZFDRPCMNL6OI.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/OLNVIHO36RGNBC5OKLVLMA56SI.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/2276GOELEJFZRCTCOXLJIXQ7L4.png)
:quality(75)/cdn.jwplayer.com/v2/media/k5ANEfax/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/eyUjAQRO/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/75LVZYXCEFFQLKF3COQ3FQD4HY.png)
:quality(75)/cdn.jwplayer.com/v2/media/eGTH9X4d/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/THmlA3V0/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/XX7B77P43FAMFHVHQ3FSCBC2AU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/7T7YBLXP55HTXMTDC5AEWIMXZE.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/I5NAJ54Y6BFJHHQHDLZOMSPE7A.png)
:quality(75)/cdn.jwplayer.com/v2/media/BdmYWOaa/poster.jpg)